Treatment of elevated intracranial pressure with hyperosmolar therapy in patients with renal failure

Neurocritical Care

Volumn 17, Issue 3, 2012, Pages 388-394

  Hirsch, Karen G ^a,e   Spock, Todd ^a   Koenig, Matthew A ^b,c   Geocadin, Romergryko G ^a,d  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b QUEEN S MEDICAL CENTER   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hypertonic saline; ICP; Intracranial pressure; Renal failure; Transtentorial herniation

Indexed keywords

MANNITOL; SODIUM; SODIUM CHLORIDE; OSMOTIC DIURETIC AGENT;

ADULT; AGED; ARTICLE; BRAIN HERNIA; CLINICAL ARTICLE; FEMALE; GLASGOW COMA SCALE; HUMAN; INTRACRANIAL HYPERTENSION; KIDNEY FAILURE; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROGNOSIS; RANKIN SCALE; RENAL REPLACEMENT THERAPY; SODIUM BLOOD LEVEL; SURVIVAL RATE; TRANSTENTORIAL HERNIATION; ACUTE DISEASE; BLOOD; BLOOD PRESSURE; DRUG EFFECT; HERNIA; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; BLOOD PRESSURE; DIURETICS, OSMOTIC; FEMALE; HERNIA; HUMANS; INTRACRANIAL HYPERTENSION; MALE; MANNITOL; MIDDLE AGED; RENAL INSUFFICIENCY; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; SALINE SOLUTION, HYPERTONIC; SODIUM; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84878198811     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-012-9676-2     Document Type: Article

References (38)

1. Qureshi AI, Geocadin RG, Suarez JI, Ulatowski JA. Long-term outcome after medical reversal of transtentorial herniation in patients with supratentorial mass lesions. Crit Care Med. 2000;28:1556-64. (Pubitemid 30324539)
2. Skoglund TS, Nellgard B. Long-term outcome after transient transtentorial herniation in patients with traumatic brain injury. Acta Anaesthesiol Scand. 2005;49:337-40. (Pubitemid 40432527)
3. Bhardwaj A. Osmotherapy in neurocritical care. Curr Neurol Neurosci Rep. 2007;7(6):513-21. (Pubitemid 350090310)
4. Harukuni I, Kirsch JR, Bhardwaj A. Osmotherapy in acute brain resuscitation. J Anesth. 2002;16:229-37.
5. Qureshi AI, Suarez JI. Use of hypertonic saline solutions in treatment of cerebral edema, intracranial hypertension. Crit Care Med. 2000;28:3301-13.
6. Paczynski RP. Osmotherapy. Basic concepts and controversies. Crit Care Clin. 1997;13:105-29. (Pubitemid 27044784)
7. Schell RM, Applegate RL II, Cole DJ. Salt, starch, and water on the brain. J Neurosurg Anesthesiol. 1996;8:178-82. (Pubitemid 26099797)
8. Zornow MH. Hypertonic saline as a safe and efficacious treatment of intracranial hypertension. J Neurosurg Anesthesiol. 1996;8:175-7. (Pubitemid 26099796)
9. Chen CH, Toung TJ, Sapirstein A, et al. Effect of duration of osmotherapy on blood-brain barrier disruption and regional cerebral edema after experimental stroke. J Cereb Blood Flow Metab. 2006;26:951-8. (Pubitemid 43980411)
10. Toung TJK, Hurn PD, Traystman RJ, et al. Global brain water increases after experimental focal cerebral ischemia: effect of hypertonic saline. Crit Care Med. 2002;30:644-9. (Pubitemid 34214631)
11. The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Use of mannitol. J Neurotrauma 2000;17:521-525.
12. Koenig MA, Bryan M, Lewin JL, Mirski MA, Geocadin RG, Stevens RD. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008;70:1023-9. (Pubitemid 351451321)
13. Qureshi A, Suarez JI, Bhardwaj A, et al. Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: effect on intracranial pressure and lateral displacement of the brain. Crit Care Med. 1998;26:440-6. (Pubitemid 28141476)
14. Huang SJ, Chang L, Han YY, et al. Efficacy and safety of hypertonic saline solutions in the treatment of severe head injury. Surg Neurol. 2006;65:539-46. (Pubitemid 43729617)
15. White H, Cook D, Venkatesh B. The use of hypertonic saline for treating intracranial hypertension after traumatic brain injury. Anesth Analg. 2006;102:1836-46. (Pubitemid 43799864)
16. Berger S, Schurer L, Hartl R, Messmer K, Baethmann A. Reduction of post-traumatic intracranial hypertension by hypertonic/hyperoncotic saline/dextran and hypertonic mannitol. Neurosurgery. 1995;37:98-107.
17. Khanna S, Davis D, Peterson B, et al. Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension in pediatric traumatic brain injury. Crit Care Med. 2000;28:1144-51. (Pubitemid 30262092)
18. Bhardwaj A, Ulatowski JA. Hypertonic saline solutions in brain injury. Curr Opin Crit Care. 2004;10:126-31. (Pubitemid 38519721)
19. Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke. 2002;33:136-40. (Pubitemid 34055759)
20. Qureshi AI, Wilson DA, Traystman RJ. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline. Neurosurgery. 1999;44:1055-63. (Pubitemid 29202866)
21. Qureshi AI, Wilson DA, Traystman RJ. Treatment of transtentorial herniation unresponsive to hyperventilation using hypertonic saline in dogs: effect on cerebral blood flow and metabolism. J Neurosurg Anesthesiol. 2002;14:22-30. (Pubitemid 34027696)
22. Suarez JI, Qureshi AI, Bhardwaj A, et al. Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med. 1998;26:1118-22. (Pubitemid 28272866)
23. Ware ML, Nemani VM, Meeker M, Lee C, Morabito DJ, Manley GT. Effects of 23.4% saline solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study. Neurosurgery. 2005;57:727-36.
24. Quinn RR, Naimark DM, Oliver MJ, Bayoumi AM. Should HD patients with AFib undergo systemic anticoagulation? A cost-utility analysis. Am J Kidney Dis. 2007;50:421-32. (Pubitemid 47304400)
25. Brouns De Deyn. Neurologic complications in renal failure: a review. Clinical Neurol Neurosurg. 2004;107(1):1-16. (Pubitemid 39556672)
26. Gondo Fujitsu, et al. Comparison of five modes of dialysis in neurosurgical patients with renal failure. Neurol Med Chir (Tokyo). 1989;29(12):1125-31.
27. Davenport A. Renal replacement therapy for the patient with acute traumatic brain injury and severe acute kidney injury. Contrib Nephrol. 2007;156:333-9.
28. Fletcher Bergman, Feucht Blostein. Continuous renal replacement therapy for refractory intracranial hypertension. Neurocrit Care. 2009;11(1):101-5.
29. Wijdicks EF, Zubkov AY. Re: Reversal of transtentorial herniation with hypertonic saline. Neurology. 2009;72(2):200.
30. Diringer MN, Zazulia AR. Osmotic therapy fact and fiction. Neurocrit Care. 2004;1(2):219-33. (Pubitemid 41278371)
31. Paczynski RP, He YY, Diringer MN, Hsu CY. Multiple-dose mannitol reduces brain water content in a rat model of cortical infarction. Stroke. 1997;28(7):1437-43.
32. Lo WD, Betz AL, Schielke GP, Hoff JT. Transport of sodium from blood to brain in ischemic brain edema. Stroke. 1987;18:150-7. (Pubitemid 17016701)
33. Jaradat MI, Molitoris BA. Cardiovascular disease in patients with chronic kidney disease. Semin Nephrol. 2002;22(6):459-73. (Pubitemid 35351258)
34. Froelich M, Ni Q, Wess C, Ougorets I, Härtl R. Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients. Crit Care Med. 2009;37(4):1433-41.
35. Kien ND, Kramer GC, White DA. Acute hypotension caused by rapid hypertonic saline infusion in anaesthetized dogs. Anesth Analg. 1991;73:597-602.
36. Zhang D, Sato T, Gong D, Fu L, Dai S, Xu H, Wu Q, Wang D, Peng Y, Sun Y. Neural reflex hypotension induced by very small dose of hypertonic NaCl solution in rats. Chin J Physiol. 2009;52(1):8-15.
37. Stiver SI, Gean AD, Manley GT. Survival with good outcome after cerebral herniation and Duret hemorrhage caused by traumatic brain injury. J Neurosurg. 2009;110(6):1242-6.
38. Kamel H, Navi BB, Nakagawa K, Hemphill JC 3rd, Ko NU. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med. 2011;39(3):554-9.